The catalytic domain of xPAK1 is sufficient to induce myosin II dependent in vivo cell fragmentation independently of other apoptotic events

Nicolas Bisson, Nazrul Islam, Luc Poitras, Steve Jean, Anne R. Bresnick, Tom Moss

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

During apoptosis, cells are fragmented into sealed packages for safe disposal by phagocytosis, a process requiring major reorganisation of the cytoskeleton. The small p21 GTPase-activated kinases (PAKs) have been implicated in regulating cytoskeletal dynamics and a subset are activated by caspase 3/7 cleavage. However, the functional importance of this activation in apoptosis remains unknown. Using early Xenopus embryos, we have dissected xPAK1 activation from other causative events in apoptosis. An apoptotic-like cell fragmentation was observed 30 min after expression of the xPAK1 catalytic domain and occurred in the absence of other markers of apoptosis. In vitro, activated xPAK1 phosphorylated the regulatory light chain (xMLC) of myosin II at threonine 18 and serine 19, events known to activate the actin-dependent ATPase of cytoskeletal myosin. In vivo, activated xPAK1 induced hyperphosphorylation of xMLC. BDM, a myosin inhibitor, and ML-7, a MLCK inhibitor, both abrogated cell fragmentation induced by activated xPAK1, and ML-7 also inhibited xPAK1 activity. Endogenous xPAK1 was cleaved during normal apoptosis and this was associated with xPAK1 activation and increased serine 19 phosphorylation of xMLC. The data show that PAK activation is sufficient for apoptotic body formation in vivo and strongly suggest that activation of myosin II is essential for this process.

Original languageEnglish (US)
Pages (from-to)264-281
Number of pages18
JournalDevelopmental Biology
Volume263
Issue number2
DOIs
StatePublished - Nov 15 2003

Fingerprint

Myosin Type II
Catalytic Domain
Apoptosis
p21-Activated Kinases
Myosins
Serine
Caspase 7
Monomeric GTP-Binding Proteins
GTP Phosphohydrolases
Threonine
Xenopus
Cytoskeleton
Phagocytosis
Caspase 3
Actins
Embryonic Structures
Phosphorylation
Light

Keywords

  • Apoptosis
  • Cell fragmentation
  • JNK
  • Myosin II
  • Ste20
  • Xenopus
  • xPAK1

ASJC Scopus subject areas

  • Developmental Biology

Cite this

The catalytic domain of xPAK1 is sufficient to induce myosin II dependent in vivo cell fragmentation independently of other apoptotic events. / Bisson, Nicolas; Islam, Nazrul; Poitras, Luc; Jean, Steve; Bresnick, Anne R.; Moss, Tom.

In: Developmental Biology, Vol. 263, No. 2, 15.11.2003, p. 264-281.

Research output: Contribution to journalArticle

@article{9421f66ae6864297993d0d245e15ceef,
title = "The catalytic domain of xPAK1 is sufficient to induce myosin II dependent in vivo cell fragmentation independently of other apoptotic events",
abstract = "During apoptosis, cells are fragmented into sealed packages for safe disposal by phagocytosis, a process requiring major reorganisation of the cytoskeleton. The small p21 GTPase-activated kinases (PAKs) have been implicated in regulating cytoskeletal dynamics and a subset are activated by caspase 3/7 cleavage. However, the functional importance of this activation in apoptosis remains unknown. Using early Xenopus embryos, we have dissected xPAK1 activation from other causative events in apoptosis. An apoptotic-like cell fragmentation was observed 30 min after expression of the xPAK1 catalytic domain and occurred in the absence of other markers of apoptosis. In vitro, activated xPAK1 phosphorylated the regulatory light chain (xMLC) of myosin II at threonine 18 and serine 19, events known to activate the actin-dependent ATPase of cytoskeletal myosin. In vivo, activated xPAK1 induced hyperphosphorylation of xMLC. BDM, a myosin inhibitor, and ML-7, a MLCK inhibitor, both abrogated cell fragmentation induced by activated xPAK1, and ML-7 also inhibited xPAK1 activity. Endogenous xPAK1 was cleaved during normal apoptosis and this was associated with xPAK1 activation and increased serine 19 phosphorylation of xMLC. The data show that PAK activation is sufficient for apoptotic body formation in vivo and strongly suggest that activation of myosin II is essential for this process.",
keywords = "Apoptosis, Cell fragmentation, JNK, Myosin II, Ste20, Xenopus, xPAK1",
author = "Nicolas Bisson and Nazrul Islam and Luc Poitras and Steve Jean and Bresnick, {Anne R.} and Tom Moss",
year = "2003",
month = "11",
day = "15",
doi = "10.1016/j.ydbio.2003.07.002",
language = "English (US)",
volume = "263",
pages = "264--281",
journal = "Developmental Biology",
issn = "0012-1606",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - The catalytic domain of xPAK1 is sufficient to induce myosin II dependent in vivo cell fragmentation independently of other apoptotic events

AU - Bisson, Nicolas

AU - Islam, Nazrul

AU - Poitras, Luc

AU - Jean, Steve

AU - Bresnick, Anne R.

AU - Moss, Tom

PY - 2003/11/15

Y1 - 2003/11/15

N2 - During apoptosis, cells are fragmented into sealed packages for safe disposal by phagocytosis, a process requiring major reorganisation of the cytoskeleton. The small p21 GTPase-activated kinases (PAKs) have been implicated in regulating cytoskeletal dynamics and a subset are activated by caspase 3/7 cleavage. However, the functional importance of this activation in apoptosis remains unknown. Using early Xenopus embryos, we have dissected xPAK1 activation from other causative events in apoptosis. An apoptotic-like cell fragmentation was observed 30 min after expression of the xPAK1 catalytic domain and occurred in the absence of other markers of apoptosis. In vitro, activated xPAK1 phosphorylated the regulatory light chain (xMLC) of myosin II at threonine 18 and serine 19, events known to activate the actin-dependent ATPase of cytoskeletal myosin. In vivo, activated xPAK1 induced hyperphosphorylation of xMLC. BDM, a myosin inhibitor, and ML-7, a MLCK inhibitor, both abrogated cell fragmentation induced by activated xPAK1, and ML-7 also inhibited xPAK1 activity. Endogenous xPAK1 was cleaved during normal apoptosis and this was associated with xPAK1 activation and increased serine 19 phosphorylation of xMLC. The data show that PAK activation is sufficient for apoptotic body formation in vivo and strongly suggest that activation of myosin II is essential for this process.

AB - During apoptosis, cells are fragmented into sealed packages for safe disposal by phagocytosis, a process requiring major reorganisation of the cytoskeleton. The small p21 GTPase-activated kinases (PAKs) have been implicated in regulating cytoskeletal dynamics and a subset are activated by caspase 3/7 cleavage. However, the functional importance of this activation in apoptosis remains unknown. Using early Xenopus embryos, we have dissected xPAK1 activation from other causative events in apoptosis. An apoptotic-like cell fragmentation was observed 30 min after expression of the xPAK1 catalytic domain and occurred in the absence of other markers of apoptosis. In vitro, activated xPAK1 phosphorylated the regulatory light chain (xMLC) of myosin II at threonine 18 and serine 19, events known to activate the actin-dependent ATPase of cytoskeletal myosin. In vivo, activated xPAK1 induced hyperphosphorylation of xMLC. BDM, a myosin inhibitor, and ML-7, a MLCK inhibitor, both abrogated cell fragmentation induced by activated xPAK1, and ML-7 also inhibited xPAK1 activity. Endogenous xPAK1 was cleaved during normal apoptosis and this was associated with xPAK1 activation and increased serine 19 phosphorylation of xMLC. The data show that PAK activation is sufficient for apoptotic body formation in vivo and strongly suggest that activation of myosin II is essential for this process.

KW - Apoptosis

KW - Cell fragmentation

KW - JNK

KW - Myosin II

KW - Ste20

KW - Xenopus

KW - xPAK1

UR - http://www.scopus.com/inward/record.url?scp=0242333966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242333966&partnerID=8YFLogxK

U2 - 10.1016/j.ydbio.2003.07.002

DO - 10.1016/j.ydbio.2003.07.002

M3 - Article

C2 - 14597201

AN - SCOPUS:0242333966

VL - 263

SP - 264

EP - 281

JO - Developmental Biology

JF - Developmental Biology

SN - 0012-1606

IS - 2

ER -